B. Nabors

发表

Central Nervous System and Peripheral Nerves

J. Olson, K. Egan, S. Rangaraju, 2018 .

Will integrin inhibitors have proangiogenic effects in the clinic?

R. Stupp, M. Weller, D. Reardon, 2009, Nature Medicine.

Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials

R. Stupp, M. Weller, T. Gorlia, 2021, Clinical Cancer Research.

Factor mRNAs Untranslated Regions of Cytokine and Angiogenic ′ within the 3 Tumors and Binds to Adenine-and Uridine-rich Elements HuR , a RNA Stability Factor , Is Expressed in Malignant Brain

G. Gillespie, P. King, B. Nabors, 2001 .

Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1

Jennie W. Taylor, Michael A. Rodriguez, Susan M. Chang, 2022, Acta Neuropathologica.

Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls

K. Triebel, J. Fiveash, A. Gerstenecker, 2022, medRxiv.

A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases

B. Guthrie, J. Markert, S. Spencer, 2016, Advances in radiation oncology.

Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma.

L. J. Lee, Zhihong Chen, Xinghua Lu, 2018, Cancer research.

Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis

Hu Li, J. Markert, Q. Ding, 2018, Journal of Neuro-Oncology.

Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma Cells

Q. Ding, Lei Yu, P. Che, 2021, Cancers.

Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.

Emily R. Gordon, S. Cooper, S. Dedhar, 2017, JCI insight.

Targeting integrins in malignant glioma

T. Mikkelsen, R. Stupp, M. Weller, 2010, Targeted Oncology.

Association of antidepressant drug use with outcome of patients with glioblastoma

Felix Boakye Oppong, R. Stupp, T. Gorlia, 2022, International journal of cancer.

A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.

J. Olson, T. Mikkelsen, P. Wen, 2013, Neuro-oncology.

Cauda equina syndrome in an ovarian malignant‐mixed müllerian tumor with leptomeningeal spread

H. Sotoudeh, W. Huh, J. Bernstock, 2019, Clinical case reports.

Phase IIa trial of cilengitide (EMD121974) single-agent therapy in patients (pts) with recurrent glioblastoma (GBM): EMD 121974-009

T. Mikkelsen, D. Schiff, J. Raizer, 2007 .

Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.

S. Heiland, R. Stupp, M. J. van den Bent, 2021, The Lancet. Digital health.

Neuro-Oncology: Current Concepts and Emerging Therapeutics

J. Laterra, B. Nabors, 2017, Neurotherapeutics.

Clinical correlates of the ability to consent to research participation in brain metastasis

K. Triebel, J. Fiveash, Kyler Mulhauser, 2020, Psycho-oncology.

Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma

Felix Boakye Oppong, R. Stupp, T. Gorlia, 2022, Neuro-oncology advances.

Implementing a Clinic-Based Telehealth Support Service (FamilyStrong) for Family Caregivers of Individuals with Grade IV Brain Tumors.

M. Bakitas, G. Williams, Jennifer Hicks, 2020, Journal of palliative medicine.

Capacity to consent to research participation in adults with metastatic cancer: comparisons of brain metastasis, non-CNS metastasis, and healthy controls.

K. Triebel, J. Fiveash, D. Vance, 2020, Neuro-oncology practice.

Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis

R. Stupp, M. Weller, T. Gorlia, 2020, International journal of cancer.

Using cognition to predict the ability to understand medical treatment in brain and metastatic cancer

K. Triebel, J. Fiveash, Kyler Mulhauser, 2019, Psycho-oncology.

The calcium binding proteins parvalbumin and calbindin‐D 28K form complementary patterns in the cat superior colliculus

C. Jeon, R. Mize, R R Mize, 1992, The Journal of comparative neurology.

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.

E. Maher, P. Wen, W. Mason, 2023, The New England journal of medicine.

Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.

J. Markert, Y. Gillespie, K. Riley, 2016, Human gene therapy. Clinical development.

Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.

Felix Boakye Oppong, R. Stupp, T. Gorlia, 2022, Neuro-Oncology.

Glioblastoma Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series and Literature Review

C. Cobbs, Keenan Piper, B. Nabors, 2019, Front. Oncol..

LTBK-09. RESULTS OF BMX-HGG STUDY: A MULTI-INSTITUTIONAL, RANDOMIZED PHASE 2 CLINICAL TRIAL OF CONCURRENT CHEMORADIATION WITH OR WITHOUT BMX-001 IN PATIENTS WITH NEWLY DIAGNOSED HIGH GRADE GLIOMA

N. Butowski, I. Batinic-Haberle, B. Nabors, 2023, Neuro-Oncology.

A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)

M. Rudek, X. Ye, D. Peereboom, 2024, Cell reports. Medicine.